Ginkgo Bioworks DNA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$3.72M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 25.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 8.31% to 14.09% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Acadian Asset Management LLC | Mutual Fund | 2026/Q3 | +588,118 | 1.4% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +519,770 | 2.2% |
| Barclays PLC | Public Company | 2026/Q3 | +485,289 | 0.8% |
| BlackRock | Mutual Fund | 2026/Q3 | +236,232 | 7.0% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +151,425 | 0.3% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +120,721 | 0.7% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +97,197 | 1.0% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +96,365 | 2.4% |
| Winton Capital Group Limited | Hedge Fund | 2026/Q3 | +69,149 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +140,485 | 0.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +640,556 | 6.4% |
| Erste Asset Management GmbH | Mutual Fund | 2026/Q3 | +589,211 | 3.8% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +439,400 | 0.8% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +372,151 | 1.4% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +327,492 | 0.9% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 18 Oct 2026 | Jason Kelly | Co-Founder, Co-COO, CEO & Director | Intent to Sell (Form 144) | -45,682 | $10.14 | – |
| 18 Oct 2026 | Reshma Shetty | Co-Founder & President | Intent to Sell (Form 144) | -22,369 | $10.14 | – |
| 18 Oct 2026 | Austin Che | Co-Founder & Head of Strategy | Intent to Sell (Form 144) | -16,058 | $10.14 | – |
| 18 Oct 2026 | Austin Che | Co-Founder & Head of Strategy | Intent to Sell (Form 144) | -2,200 | $10.38 | – |
| 18 Oct 2026 | Bartholomew Canton | Chief Technology Officer | Intent to Sell (Form 144) | -18,803 | $10.14 | – |
| 18 Oct 2026 | Steven Coen | Chief Financial Officer | Intent to Sell (Form 144) | -766 | $10.14 | – |
| 18 Oct 2026 | Jason Kelly | Co-Founder, Co-COO, CEO & Director | Derivative Exercise and Sale | -45,682 | $10.14 | 129,065 |
| 18 Oct 2026 | Reshma Shetty | Co-Founder & President | Derivative Exercise and Sale | -22,369 | $10.14 | 453,951 |
| 18 Oct 2026 | Bartholomew Canton | Chief Technology Officer | Derivative Exercise and Sale | -18,803 | $10.14 | 356,329 |
| 18 Oct 2026 | Steven Coen | Chief Financial Officer | Derivative Exercise and Sale | -766 | $10.14 | 50,168 |
| 15 Oct 2026 | Jason Kelly | Co-Founder, Co-COO, CEO & Director | Derivative Exercise and Retained | +35,802 | – | 129,065 |
| 15 Oct 2026 | Reshma Shetty | Co-Founder & President | Derivative Exercise and Retained | +17,529 | – | 453,951 |
| 15 Oct 2026 | Bartholomew Canton | Chief Technology Officer | Derivative Exercise and Retained | +17,761 | – | 356,329 |
| 15 Oct 2026 | Steven Coen | Chief Financial Officer | Derivative Exercise and Retained | +720 | – | 50,168 |
| 4 Oct 2026 | Steven Coen | Chief Financial Officer | Automatic Disposition | -2,403 | $15.00 | 49,448 |
| 4 Oct 2026 | Steven Coen | Chief Accounting Officer | Intent to Sell (Form 144) | -2,403 | $15.00 | – |
| 16 Sep 2026 | Austin Che | Co-Founder & Head of Strategy | Intent to Sell (Form 144) | -2,200 | $7.29 | – |
| 14 Sep 2026 | Christian O. Henry | Independent Director | Open Market Disposition | -5,000 | $7.08 | 19,310 |
| 23 Aug 2026 | Steven Coen | Chief Financial Officer | Intent to Sell (Form 144) | -330 | $6.98 | – |
| 23 Aug 2026 | Steven Coen | Chief Financial Officer | Derivative Exercise and Sale | -330 | $6.98 | 51,851 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 9,490,310 | 14.1% | 3.9 |
| 15 Oct 2026 | 8,294,322 | 12.3% | 1.9 |
| 30 Sep 2026 | 7,315,221 | 10.9% | 2.7 |
| 15 Sep 2026 | 7,166,128 | 10.6% | 7.2 |
| 31 Aug 2026 | 6,865,017 | 10.2% | 5.5 |
| 14 Aug 2026 | 5,596,447 | 8.3% | 4.3 |
No comments yet — be the first to weigh in on DNA.
Sign in to join the discussion.